Rufu Chen

2.4k total citations
41 papers, 1.2k citations indexed

About

Rufu Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rufu Chen has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 21 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Rufu Chen's work include Pancreatic and Hepatic Oncology Research (15 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (8 papers). Rufu Chen is often cited by papers focused on Pancreatic and Hepatic Oncology Research (15 papers), RNA modifications and cancer (11 papers) and Cancer-related molecular mechanisms research (8 papers). Rufu Chen collaborates with scholars based in China, United States and Hong Kong. Rufu Chen's co-authors include Quanbo Zhou, Changhao Chen, Shangyou Zheng, Qing Lin, Yuming Luo, Huilin Ye, Zhihua Li, Lusheng Wei, Yue Zhao and Guolin Li and has published in prestigious journals such as Journal of Clinical Investigation, Nature Genetics and JNCI Journal of the National Cancer Institute.

In The Last Decade

Rufu Chen

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rufu Chen China 18 801 546 433 197 138 41 1.2k
Leyuan Zhou China 15 843 1.1× 762 1.4× 288 0.7× 259 1.3× 89 0.6× 37 1.3k
Yu Lou China 15 525 0.7× 403 0.7× 416 1.0× 285 1.4× 110 0.8× 28 1.1k
Rufu Chen China 18 942 1.2× 947 1.7× 295 0.7× 132 0.7× 140 1.0× 28 1.3k
Qi‐Nian Wu China 17 724 0.9× 468 0.9× 240 0.6× 148 0.8× 88 0.6× 33 1.1k
Yun Che China 21 752 0.9× 568 1.0× 349 0.8× 163 0.8× 155 1.1× 43 1.2k
Shengjia Shi China 13 448 0.6× 391 0.7× 256 0.6× 211 1.1× 109 0.8× 25 944
Chuanyuan Wei China 19 1.1k 1.4× 729 1.3× 343 0.8× 261 1.3× 86 0.6× 52 1.6k
Xuefeng He China 13 764 1.0× 546 1.0× 218 0.5× 290 1.5× 50 0.4× 33 1.1k
Baochi Ou China 17 602 0.8× 302 0.6× 403 0.9× 224 1.1× 71 0.5× 26 1.1k
Leilei Liang China 20 832 1.0× 559 1.0× 201 0.5× 191 1.0× 97 0.7× 41 1.1k

Countries citing papers authored by Rufu Chen

Since Specialization
Citations

This map shows the geographic impact of Rufu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rufu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rufu Chen more than expected).

Fields of papers citing papers by Rufu Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rufu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rufu Chen. The network helps show where Rufu Chen may publish in the future.

Co-authorship network of co-authors of Rufu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Rufu Chen. A scholar is included among the top collaborators of Rufu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rufu Chen. Rufu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Yu, et al.. (2024). Nudt21-mediated alternative polyadenylation of MZT1 3′UTR contributes to pancreatic cancer progression. iScience. 27(2). 108822–108822. 7 indexed citations
3.
Xia, Renpeng, Chonghui Hu, Yuancheng Ye, et al.. (2023). HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1. International Journal of Oncology. 62(4). 9 indexed citations
4.
Wu, Guandi, Jiachun Su, Lingxing Zeng, et al.. (2023). LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer. Cell Death and Differentiation. 30(10). 2213–2230. 13 indexed citations
5.
Kong, Yao, Yuming Luo, Yue Zhao, et al.. (2023). Mutant KRAS Mediates circARFGEF2 Biogenesis to Promote Lymphatic Metastasis of Pancreatic Ductal Adenocarcinoma. Cancer Research. 83(18). 3077–3094. 33 indexed citations
6.
Li, Rui, Xudong Huang, Jialiang Zhang, et al.. (2023). Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma. Nature Genetics. 55(12). 2224–2234. 46 indexed citations
7.
Chen, Zhihong, Ning Shi, Cheng Xing, et al.. (2023). A novel clinical model for risk prediction and stratification of new-onset diabetes mellitus after distal pancreatectomy. HepatoBiliary Surgery and Nutrition. 12(6). 868–881. 2 indexed citations
8.
Cai, Shi‐Ying, et al.. (2023). Characterization of gut microbiota in patients with stage 3–4 chronic kidney disease: a retrospective cohort study. International Urology and Nephrology. 56(5). 1751–1762. 6 indexed citations
9.
Luo, Yuming, Zhihua Li, Yao Kong, et al.. (2022). KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer. Journal of Clinical Investigation. 132(14). 42 indexed citations
10.
Deng, Junge, Jialiang Zhang, Kaijing Liu, et al.. (2021). N6 -methyladenosine–Mediated Upregulation of WTAPP1 Promotes WTAP Translation and Wnt Signaling to Facilitate Pancreatic Cancer Progression. Cancer Research. 81(20). 5268–5283. 69 indexed citations
11.
Ye, Ying, Jialiang Zhang, Kaiyu Zhu, et al.. (2021). Genome-wide identification and characterization of circular RNA m6A modification in pancreatic cancer. Genome Medicine. 13(1). 183–183. 17 indexed citations
12.
Zhou, Quanbo, Zhiguo Li, Huilin Ye, et al.. (2019). Intraoperative Radiotherapy for Borderline Resectable Pancreatic Cancer: A Retrospective Analysis. 4(1). 1 indexed citations
13.
Li, Ye‐Xiong, Qinfu Feng, Jing Jin, et al.. (2019). Experts’ consensus on intraoperative radiotherapy for pancreatic cancer. Cancer Letters. 449. 1–7. 12 indexed citations
14.
Chen, Changhao, Yuming Luo, Wang He, et al.. (2019). Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. Journal of Clinical Investigation. 130(1). 404–421. 282 indexed citations
15.
Wei, Lusheng, Huilin Ye, Guolin Li, et al.. (2018). Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer. Cell Death and Disease. 9(11). 1065–1065. 134 indexed citations
16.
Li, Doudou, Changhao Chen, Yu Zhou, et al.. (2015). Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer. Medicine. 94(35). e1345–e1345. 10 indexed citations
17.
Guo, Ning, Rufu Chen, Zhihua Li, et al.. (2011). Hepatitis C virus core upregulates the methylation status of the RASSF1A promoter through regulation of SMYD3 in hilar cholangiocarcinoma cells. Acta Biochimica et Biophysica Sinica. 43(5). 354–361. 30 indexed citations
18.
19.
Zhou, Quanbo, et al.. (2007). [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells].. PubMed. 87(39). 2780–4. 1 indexed citations
20.
Chen, Rufu. (2000). Inhibition of growth of human cholangiocarcinoma in nude mice by vascular endthelial frowth factor antisense phosphorothioate oligodeoxynucleotides. Zhonghua shiyan waike zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leyuan Zhou Breakdown of academic impact, for papers by Yu Lou Breakdown of academic impact, for papers by Rufu Chen Breakdown of academic impact, for papers by Qi‐Nian Wu Breakdown of academic impact, for papers by Yun Che Breakdown of academic impact, for papers by Shengjia Shi Breakdown of academic impact, for papers by Chuanyuan Wei Breakdown of academic impact, for papers by Xuefeng He Breakdown of academic impact, for papers by Baochi Ou Breakdown of academic impact, for papers by Leilei Liang
Rankless by CCL
2026